141 – 150 of 176
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
GDNF is not required for catecholaminergic neuron survival in vivo.
(
- Contribution to journal › Letter
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.
(
- Contribution to journal › Article
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Direct Conversion of Human Fibroblasts to Induced Neurons
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors.
(
- Contribution to journal › Article
-
Mark
Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain.
(
- Contribution to journal › Article
-
Mark
Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.
(
- Contribution to journal › Article
-
Mark
Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Article